CA
RPTX

CHI Advisors’s Repare Therapeutics RPTX Stock Holding History

CHI Advisors’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$35.8M Sell
2,966,674
-32,060
-1% -$331K 14.2% 2
2023
Q2 		$31.7M Buy
2,998,734
+795
+0% +$8.19K 9.63% 5
2023
Q1 		$29.5M Buy
2,997,939
+197,813
+7% +$2.27M 7.83% 5
2022
Q4 		$41.2M Sell
2,800,126
-269,721
-9% -$4.03M 10.97% 4
2022
Q3 		$37.2M Buy
3,069,847
+423,066
+16% +$5.45M 10.01% 4
2022
Q2 		$37M Buy
2,646,781
+65,684
+3% +$773K 14.14% 3
2022
Q1 		$36.8M Buy
2,581,097
+368,841
+17% +$5.47M 15.63% 2
2021
Q4 		$46.7M Sell
2,212,256
-20,527
-0.9% -$484K 15.49% 2
2021
Q3 		$58.6M Sell
2,232,783
-306,861
-12% -$9.91M 17.1% 2
2021
Q2 		$79.2M Sell
2,539,644
-21,059
-0.8% -$690K 18.42% 1
2021
Q1 		$78.6M Buy
2,560,703
+28,553
+1% +$970K 15.73% 3
2020
Q4 		$86.9M Buy
2,532,150
+1,656
+0.1% +$49.5K 24.47% 1
2020
Q3 		$77.9M Buy
2,530,494
+27,086
+1% +$717K 27.7% 1
2020
Q2 		$77.7M Buy
+2,503,408
New +$80.4M 30.3% 1

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CHI Advisors's RPTX Position: Q3 2023 in Review

CHI Advisors reduced its Repare Therapeutics (RPTX) stake by 1.1% in Q3 2023, selling an estimated $331K and leaving 2,966,674 shares worth $35.8M. The position accounts for 14.2% of the portfolio, ranked #2.

CHI Advisors first reported a position in RPTX in Q2 2020 and has held it in 14 quarters since. The position peaked at $86.9M in Q4 2020. 76 funds tracked by Wall St. Rank hold RPTX as of Q3 2023.

  • CHI Advisors held 2,966,674 shares of Repare Therapeutics worth $35.8M as of Q3 2023.
  • CHI Advisors sold 32,060 Repare Therapeutics shares in Q3 2023, an estimated $331K.
  • Repare Therapeutics made up 14.2% of CHI Advisors's portfolio in Q3 2023, its #2 holding.
  • CHI Advisors first reported a position in Repare Therapeutics in Q2 2020 and has held it in 14 quarters since.
  • CHI Advisors's Repare Therapeutics position peaked at $86.9M in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.